▲ 0.00%
prev close
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
Congressional Trades
4
All tracked trades
Members Trading
3
Unique members
Net Activity
+0
2 buys · 2 sells
Members Who Traded This Stock
4 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2025-12-29 | IQVIQVIA Holdings Inc. | Buy | $15,001 - $50,000 | 187d ago | — | |
| 2025-10-02 | IQVIQVIA Holdings Inc. | Sell | $1,001 - $15,000 | 249d ago | — | |
| 2025-05-15 | IQVIQVIA Holdings Inc. | Sell | $1,001 - $15,000 | 417d ago | — | |
| 2025-04-08 | IQVIQVIA Holdings Inc. | Buy | $15,001 - $50,000 | 440d ago | — |
2025-12-29
Markwayne Mullin
IQV
Amount
$15,001 - $50,000
Filed
187d ago
2025-10-02
John Boozman
IQV
Amount
$1,001 - $15,000
Filed
249d ago
2025-05-15
Rob Bresnahan
IQV
Amount
$1,001 - $15,000
Filed
417d ago
2025-04-08
Rob Bresnahan
IQV
Amount
$15,001 - $50,000
Filed
440d ago
Recent News
Powered by Polygon.io
Global Clinical Trials Market to Reach $176.32 Billion by 2030 as AI and Decentralized Research Accelerate Growth
Pharmacovigilance Automation Market Size to Reach USD 5.25 Billion by 2035 | SNS Insider
Global Decentralized Clinical Trials Market Size/Share Worth USD 38.3 Billion by 2035 at a 14.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Dark Horse Consulting Group and KunTuo Announce Memorandum of Understanding Providing Cell and Gene Therapy Developers with an Accelerated Path to Clinical Development in China
8 Stocks Yet to Join the Rally With Upside Potential of Up to 85%
Trade Timeline
Congressional activity, newest first
Markwayne Mullin
2025-12-29 · Purchase
$15,001 - $50,000
John Boozman
2025-10-02 · Sale
$1,001 - $15,000
Rob Bresnahan
2025-05-15 · Sale
$1,001 - $15,000
Rob Bresnahan
2025-04-08 · Purchase
$15,001 - $50,000